Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
Alliance Newsletter: On Call Spring 2026 April 29, 2026
Alliance Supports Legislation to Modernize the Medicare Physician Fee Schedule April 24, 2026
Alliance Submits Comments to CMS on “CRUSH” Regulation RFI March 30, 2026
Alliance of Specialty Medicine Submits Comments on MAPD Advance Notice February 20, 2026© 2026 Alliance of Specialty Medicine. All rights reserved. Website designed and developed by Orpheus, Inc..

